162 related articles for article (PubMed ID: 6194518)
1. Antidepressant properties of some phosphodiesterase inhibitors.
Przegaliński E; Bigajska K
Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
[TBL] [Abstract][Full Text] [Related]
2. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
Wachtel H; Schneider HH
Neuropharmacology; 1986 Oct; 25(10):1119-26. PubMed ID: 2946976
[TBL] [Abstract][Full Text] [Related]
3. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
Ransjö M; Fredholm BB; Lerner UH
Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
[TBL] [Abstract][Full Text] [Related]
4. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
[TBL] [Abstract][Full Text] [Related]
5. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
Wachtel H
J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991
[TBL] [Abstract][Full Text] [Related]
6. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.
Wachtel H
Neuropharmacology; 1983 Mar; 22(3):267-72. PubMed ID: 6302550
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle.
Halene TB; Siegel SJ
J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
10. The central action of carbamazepine as a potential antidepressant drug.
Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
Undem BJ; Meeker SN; Chen J
J Pharmacol Exp Ther; 1994 Nov; 271(2):811-7. PubMed ID: 7965800
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate.
O'Donnell JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1168-78. PubMed ID: 8383740
[TBL] [Abstract][Full Text] [Related]
13. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
Coqueret O; Boichot E; Lagente V
Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
[TBL] [Abstract][Full Text] [Related]
14. Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase.
Schmiechen R; Schneider HH; Wachtel H
Psychopharmacology (Berl); 1990; 102(1):17-20. PubMed ID: 2392503
[TBL] [Abstract][Full Text] [Related]
15. Forskolin and phosphodiesterase inhibitors release adenosine but inhibit morphine-evoked release of adenosine from spinal cord synaptosomes.
Nicholson D; White TD; Sawynok J
Can J Physiol Pharmacol; 1991 Jun; 69(6):877-85. PubMed ID: 1717120
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
Danahay H; Broadley KJ
Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
[TBL] [Abstract][Full Text] [Related]
17. The stimulatory action of phosphodiesterase inhibitors on the flexor reflex of the hind limb in the spinal rat.
Przegaliński E; Rawłów A
J Neural Transm; 1982; 55(1):9-17. PubMed ID: 6182270
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant profile of bupropion and three metabolites in mice.
Martin P; Massol J; Colin JN; Lacomblez L; Puech AJ
Pharmacopsychiatry; 1990 Jul; 23(4):187-94. PubMed ID: 2116631
[TBL] [Abstract][Full Text] [Related]
19. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
[TBL] [Abstract][Full Text] [Related]
20. Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones.
Saccomano NA; Vinick FJ; Koe BK; Nielsen JA; Whalen WM; Meltz M; Phillips D; Thadieo PF; Jung S; Chapin DS
J Med Chem; 1991 Jan; 34(1):291-8. PubMed ID: 1992129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]